Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 3, Issue 3, 2022

Acute gouty arthritis attacks induced by a great toe injury: a case report and literature review

Download as PDF

DOI: 10.23977/medsc.2022.030311 | Downloads: 12 | Views: 702

Author(s)

Jun Yang 1, Li Liu 2, Xiaopan Nie 2, Anni Jiang 2

Affiliation(s)

1 Department of Urology, Zigui County Hospital of Traditional Chinese Medicine, Yichang, 443600, Hubei, China
2 Department of Clinical Psychology, People's Hospital of Wuhan University, Wuhan, 430061, Hubei, China

Corresponding Author

Anni Jiang

ABSTRACT

Introduction: Gouty arthritis usually occurs in patients with hyperuricemia and can be induced by a variety of factors. Here, we describe a case of acute gouty arthritis attacks induced by a great toe injury and was successfully treated by benzbromarone and ibuprofen. Patient concerns: A 27-year-old Asian man with hyperuricemia informed us his first metatarsophalangeal joint of left foot began to redness and swelling, accompanied by severe pain presented 8 days after the toenail injury. Diagnoses: Laboratory tests confirmed as gouty arthritis with no signs of infection, but serum uric acid was significantly higher than normal at 523 μmol/L. Interventions: Drug treatment was adopted, including benzbromarone 100 mg daily, ibuprofen pills 75mg twice a day, and sodium bicarbonate tablets 0.5g three times a day. Outcomes: All of his symptoms of acute gouty arthritis attacks gradually disappear after drug treatment for a week and blood uric acid had dropped to 87 μmol/L two weeks later. Conclusion: When patients with a broken great toe present with symptoms of first metatarsophalangeal joint began to redness and swelling, accompanied by severe pain, acute gouty arthritis attacks should also be considered, and the drug treatment is effective. Abbreviation: GA = Gouty arthritis, MSU = Monosodium urate, ESRD = End-stage renal disease.

KEYWORDS

Gouty arthritis, hyperuricemia, injury, drug treatment, benzbromarone

CITE THIS PAPER

Jun Yang, Li Liu, Xiaopan Nie, Anni Jiang, Acute gouty arthritis attacks induced by a great toe injury: a case report and literature review. MEDS Clinical Medicine (2022) Vol. 3: 65-71. DOI: http://dx.doi.org/10.23977/medsc.2022.030311.

REFERENCES

[1] Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther2006;8 Suppl 1(Suppl 1):S1.
[2] Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis care & research. 2012 Oct;64(10):1431-46.
[3] Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al. 2012. American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis care & research2012 Oct;64(10):1447-61.
[4] Wilson L, Saseen JJ. Gouty Arthritis: A Review of Acute Management and Prevention. Pharmacotherapy. 2016 Aug;36(8):906-22.
[5] Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. Clin Rheumatol. 2020 Apr;39(4):1061-63.
[6] Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am. 2014. May;40(2):155-75.
[7] Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223.
[8] Weaver AL. Epidemiology of gout. Cleve Clin J Med. 2008. Jul;75 Suppl 5:S9-12.
[9] Kiadaliri AA, Uhlig T, Englund M. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. Scand J Rheumatol. 2018. Sep;47(5):410-17.
[10] Mohamed AZ, Wallach WJ, Lu S, Zwiebel B, Hoots G. Acute gouty arthritis following percutaneous cryoablation of renal cell carcinoma. Radiology case reports. 2019. Nov;14(11):1432-37.
[11] Bottiglieri S, Tierson N, Patel R, Mo JH, Mehdi S. Gemcitabine-induced gouty arthritis attacks. J Oncol Pharm Pract. 2013 Sep;19(3):284-8.
[12] Einarson TR, Turchet EN, Goldstein JE, MacNay KR. Gout-like arthritis following cimetidine and ranitidine. Drug intelligence & clinical pharmacy. 1985. Mar;19(3):201-2.
[13] Van Veen TR, Haeri S. Gout in pregnancy: a case report and review of the literature. Gynecologic and obstetric investigation. 2015;79(4):217-21.
[14] Alici T, Imren Y, Erdil M, Gundes H. Gouty arthritis at interphalangeal joint of foot after sildenafil use: A case report. International journal of surgery case reports. 2013;4(1):11-4.
[15] Dhaese S, Stryckers M, Van Der Meersch H, Terryn W, Van Laecke S. Gouty arthritis of the spine in a renal transplant patient: a clinical case report: an unusual presentation of a common disorder. Medicine. 2015 Apr;94(13):e676.
[16] Choi DH, Lee HS. A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma. World journal of gastroenterology. 2010. Feb 14;16(6):778-81.
[17] Ji LL, Hao YJ, Zhang ZL. [A case of gout secondary to primary myelofibrosis]. Beijing da xue xue bao Yi xue ban = Journal of Peking University Health sciences. 2018. Dec 18;50(6):1117-19.
[18] Pela I, Seracini D, Lavoratti G, Materassi M. [Acute gouty arthritis in adolescents with renal transplants]. La Pediatria medica e chirurgica : Medical and surgical pediatrics. 1999. May-Jun;21(3):135-7.
[19] Calderon MS, Chung KC. Case report. Initial manifestation of gout after carpal tunnel release. British journal of plastic surgery. 1999. Jan;52(1):76-7.
[20] Richette P, Bardin T. Gout. Lancet. 2010. Jan 23;375(9711):318-28.
[21] Baker JF, Schumacher HR. Update on gout and hyperuricemia. Int J Clin Pract. 2010. Feb;64(3):371-7.
[22] Cleophas MCP, Crişan TO, Klück V, Hoogerbrugge N, Netea-Maier RT, Dinarello CA et al. Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Res Ther. 2019. Feb 6;21(1):50.
[23] McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961. Mar;54:452-60.
[24] Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016. Oct 22;388(10055):2039-52.
[25] Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015. Nov;11(11):649-62.
[26] Taniguchi A, Kamatani N. Control of renal uric acid excretion and gout. Curr Opin Rheumatol. 2008. Mar;20(2):192-7.
[27] Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007. Aug;46(8):1372-4.
[28] Zhang. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2006;65(10):1312-24.
[29] Krishnan E, Chen L. Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009. Arthritis Res Ther. 2013 Nov 6;15(6):R181.
[30] Robinson PC, Kempe S, Tebbutt I, Roberts L. Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. Int J Rheum Dis. 2017 Jun;20(6):779-84.
[31] Liu R, Han C, Wu D, Xia X, Gu J, Guan H et al. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. BioMed research international. 2015;2015:762820.
[32] Ohno I, Ichida K, Okabe H, Hikita M, Uetake D, Kimura H et al. Frequency of gouty arthritis in patients with end-stage renal disease in Japan. Internal medicine (Tokyo, Japan).2005. Jul;44(7):706-9.
[33] Ifudu O, Tan CC, Dulin AL, Delano BG, Friedman EA. Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1994. Mar;23(3):347-51.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4695
Visits: 204994

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.